GlucoTrack Inc

For the period ended Dec 31, 2023. Filed Mar 28, 2024.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2023 · Filed Mar 28, 2024

GCTK$1.39-32.2%Stored close · as of Oct 29, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Statements of Cash Flows

	2023	2022
Cash flows from operating activities:
Loss for the year	(7,097)	(4,435)
Adjustments to reconcile loss for the year to net cash used in operating activities:
Depreciation	13	23
Capital loss from sale of property and equipment	-	1
Stock-based compensation	281	439
Issuance of restricted shares as compensation to directors	54	48
Linkage difference on principal of loans from stockholders	1	11
Changes in assets and liabilities:
Increase in other current assets	(309)	(28)
Increase in accounts payable	167	74
Increase (Decrease) in other current liabilities	332	138
Net cash used in operating activities	(6,558)	(3,729)
Cash flows from investment activities:
Proceeds from sale of property and equipment	-	2
Purchase of property and equipment	-	(1)
Net cash provided by investment activities	-	1
Cash flows from financing activities
Net proceeds received from underwritten U.S. public offering (Note 5B)	8,730	-
Net cash provided by financing activities	8,730	-
Effect of exchange rate changes on cash and cash equivalents	(1)	(54)
Change in cash, cash equivalents, and restricted cash	2,171	(3,782)
Cash, cash equivalents, and restricted cash at beginning of the year	2,331	6,113
Cash, cash equivalents, and restricted cash at end of the year	4,502	2,331

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.